Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

Share Price is delayed by 15 minutes
Get Live Data
77.90    1.20 (1.56%)
Bid:
77.70
Ask:
77.90
Spread: 0.20 (0.257%)
Market Cap: £374.68m
CHRY Live PriceLast checked at - London Stock Exchange

Intraday Chrysalis Inves Share Chart

Update note from QuotedData

27 Feb 2025 15:39

RNS Number : 7680Y
Chrysalis Investments Limited
27 February 2025
Β 

Chrysalis Investments - Update from QuotedData

27th February 2025

Return to form

Chrysalis Investments Limited (CHRY) has experienced decentΒ net asset value (NAV)Β and share price growth recently. With the bulk of the proceeds from the disposals of Graphcore and Featurespace received, and the termΒ loan facilityΒ drawn down, CHRY is making good progress with itsΒ share buybackΒ programme (see page 4). As of publication, 46,183,261 shares had been bought back, around 7.8% of CHRY's issuedΒ share capital, and this is boosting itsΒ NAV. CHRY has now returned about Β£45m of its Β£100m target and is well placed to press ahead with this, as it had a totalΒ liquidityΒ position (available cash and credit) of approximately Β£144m at end December 2024.

The bulk of theΒ portfolioΒ is performing well - in its recent results, CHRY said that all portfolio companies have seen profits rise or losses narrow - and Klarna'sΒ IPOΒ still looks likely at some point this year. While there is a good case that it might soon be time to make new investments, the focus for 2025 will remain on narrowing theΒ discount to NAV, which is in much better shape than it was a year ago, but still has room for improvement.

Full Research:

https://quoteddata.com/research/chrysalis-investments-return-to-form-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Chrysalis Investments Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAFZGZZKNRGKZM
Date   Source Headline
18th May 20264:11 pmRNSDirector/PDMR Shareholding
12th May 202610:11 amRNSDirector/PDMR Shareholding
7th May 202611:38 amRNSDirector/PDMR Shareholding
5th May 20267:44 amRNSQuarterly NAV Announcement and Trading Update
5th May 20267:01 amRNSManagement Arrangements and Self-Managed Model
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20264:01 pmRNSResult of AGM
31st Mar 20263:26 pmRNSResults of AGM
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:24 pmRNSResults of EGM
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20269:50 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20269:59 amRNSTransaction in Own Shares
13th Mar 20269:59 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:21 pmRNSNotice of AGM
10th Mar 20264:21 pmRNSNotice of AGM
10th Mar 20267:01 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSLiquidity and Cash Update
9th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.